Well, I really appreciate that.

If the Government is really serious about speeding up the slow approval process and reducing health costs, a process like this would help to do it.

So I have heard a lot of comments from my colleagues on both sides of the aisle about concerns about doing research with different--and I don't know what the right word is--but when you change the formula a little bit on fentanyl, and they…

I believe they should not be prevented or discouraged from providing the service because of outdated reimbursement policies.

I don't think it's a partisan issue. I think you'd find support on both sides of the aisle to change the laws.

May I get your commitment that your staff at HHS and CMS will work swiftly to allow such a waiver?

I know that there have been some issues. But for rural areas the competitive bid reimbursement adjustment has been deadly for durable medical equipment suppliers.

He certainly did. It was remarkable and memorable. I will certainly always remember that great attitude and just all his other great attributes that we heard about tonight.

A number of my constituents are concerned, but we also want to make sure we have hospitals because, if you shut one down, it's not like there's another one right around the corner.

I thank the chairman for giving me this opportunity. Unlike Mr. Walden, who met him back in 1988, I did not have the opportunity to fall within Ray's orbit until he became the staff director at the Energy and Commerce Committee about 13…

I think we have to take a look at the Stark Act.

I want you to think about ways we can help blow up and make the market more innovative.

Well, if you have language I would be very interested in it because I would like to blow up the way we do the reimbursements so we can blow up the medical system and make costs come down.

This is why the Academy is supporting policy that ensures access to drugs for office space use, such H.R. 2871, the Preserving Patient Access to Compounded Medications Act, introduced by Congressman Morgan Griffith.

And I would just ask, in relationship to 503A, because we were talking about it earlier, if that didn't contemplate office use, then why has FDA allowed it up until this point in time?

While we had criminal conduct by NECC, we also had timid lawyers at the FDA.

As Ms. DeGette said, there has got to be a balance.

We have to try to find that balance, because we have situations that, in all fairness, I wasn't aware that one of the solutions to resolve the problem was that we were going to have folks going and picking up drugs.

I think sometimes we are talking at cross-purposes because I don't think any of us want to see somebody like NECC coming back.

Commissioner Gottlieb, of all the folks that we have dealt with at that level, is probably the most responsive that the committee has found.

And I disagree, just based on the debate that we had when we were doing this a number of years ago in 2013, because we anticipated there would be continued office use.

If you look at the timetable there on their chart... you told them you were about to do it, and 4 days later, they were, like, 'OK, OK, we'll do it voluntarily.'

We would no longer be dependent on China for a large percentage of our rare earth elements.

There is a lot of potential for coal in my district in rare earth and combining the two to create a product that is more profitable.

I think that is why we find ourselves back at the table, that we want to update and modernize NAFTA from where it was 30-some-odd years ago.